| Literature DB >> 33815018 |
Masanori Maeda1,2, Hitoshi Mutai2,3, Yumi Toya1, Yusuke Maekawa1, Takatoshi Hitai1, Satoshi Katai1.
Abstract
OBJECTIVE: Upper limb paralysis, which is a sequela of stroke, limits patients' activities of daily living and lowers quality of life. The objective of this study was to examine the effects of peripheral nerve stimulation on hemiparetic upper limb functional recovery in chronic stroke patients undergoing low-frequency repetitive transcranial magnetic stimulation and occupational therapy.Entities:
Keywords: Peripheral nerve stimulation; occupational therapy; repetitive transcranial magnetic stimulation; stroke; upper limb function
Year: 2020 PMID: 33815018 PMCID: PMC8008372 DOI: 10.1177/1569186120901633
Source DB: PubMed Journal: Hong Kong J Occup Ther ISSN: 1569-1861 Impact factor: 0.917
Figure 1.Flow diagram of the study.
OT: occupational therapy; PNS: peripheral nerve stimulation; rTMS: repetitive transcranial magnetic stimulation.
Comparisons in the characteristics and pre-intervention assessments between the PNS and control groups.
| Characteristics and assessments | PNS group (n = 11) | Control group (n = 11) | p |
|---|---|---|---|
| Age | |||
| Median (IQR) | 74 (70.0–76.5) | 71 (65.0–81.5) | 0.869[ |
| Gender | |||
| Male/Female | 6/5 | 7/4 | 1.000[ |
| Stroke type | |||
| Haemorrhagic/ischaemic | 4/7 | 4/7 | 1.000[ |
| Paralysis side | |||
| Right/Left | 4/7 | 5/6 | 1.000[ |
| Years after stroke onset | |||
| Median (IQR) | 4.0 (2.7–7.7) | 2.8 (2.2–3.7) | 0.158[ |
| Botulinum treatment | |||
| Yes/No | 2/9 | 2/9 | 1.000[ |
| Number of times patients underwent rTMS and OT inpatient programme | |||
| Median (IQR) | 3 (1.5–4.5) | 3 (1.0–5.0) | 0.737[ |
IQR: interquartile range; OT: occupational therapy; PNS: peripheral nerve stimulation; rTMS: repetitive transcranial magnetic stimulation.
aExact Mann–Whitney U test.
bFisher’s exact test.
Comparisons in upper extremity function between pre- and post-intervention, within and between the PNS and control groups.
| PNS group (n = 11) | Control group (n = 11) | Baseline (PNS versus control, pre-intervention) | PNS group versus control group (change in score) | PNS group (pre- versus post-intervention) | Control group (pre- versus post-intervention) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper limb function | Pre-intervention | Post-intervention | Change in score | Pre-intervention | Post-intervention | Change in score | p | p | r | p | r | p | r |
| WMFT | 5.6 (3.9–6.8) | 5.1 (3.7–6.7) | −0.14 (−0.24 to 0) | 5.9 (3.7–6.7) | 5.9 (3.6–6.7) | −0.14 (−0.24 to 0.01) | 0.670 | 0.577 | 0.12 | 0.014 | 0.51 | 0.054 | 0.42 |
| FMA (total U/E) | 49 (32.5–55.5) | 55 (38–58.5) | 5 (3.5–6.0) | 40 (32–57) | 42 (37.5–58.5) | 2 (1–4) | 0.921 | 0.085 | 0.37 | 0.005 | 0.61 | 0.009 | 0.57 |
| Shoulder, elbow, forearm | 29 (22–32) | 30 (25–32.50) | 2 (1.0–2.5) | 27 (23–33) | 29 (25.5–33.5) | 1 (1.0–1.5) | 0.895 | 0.432 | 0.17 | 0.012 | 0.77 | 0.015 | 0.72 |
| Wrist | 6 (4.5–7.5) | 8 (5.5–9.0) | 0 (0–1.0) | 7 (5–9) | 7 (5–8) | 0 (0–1.0) | 0.407 | 0.789 | 0.06 | 0.174 | 0.48 | 0.203 | 0.41 |
| Hand | 8 (6.00–10.5) | 11 (8.0–12.5) | 2 (1.0–2.5) | 8 (4.50–11.0) | 10 (5–12) | 0 (0–1.0) | 0.692 | 0.021 | 0.49 | 0.008 | 0.80 | 0.120 | 0.47 |
| Coordination/ speed | 4 (0–5) | 5 (0–5) | 0 (0–0) | 0 (0–2) | 0 (0–3) | 0 (0–0.5) | 0.138 | 0.280 | 0.23 | 1 | 0.30 | 0.149 | 0.48 |
| MAL-AOU | 1.31 (0.76–3.06) | 1.69 (1.10–3.40) | 0.29 (0.08–0.34) | 0.9 (0.50–1.94) | 1.33 (0.85–2.19) | 0.20 (−0.04 to 0.57) | 0.250 | 0.818 | 0.06 | 0.009 | 0.57 | 0.124 | 0.34 |
| MAL-QOM | 1.10 (0.70–3.11) | 1.70 (1.15–3.61) | 0.40 (0.03–0.52) | 0.9 (0.50–1.99) | 1.36 (0.90–2.47) | 0.20 (0.03–0.74) | 0.200 | 0.869 | 0.04 | 0.014 | 0.54 | 0.076 | 0.39 |
AOU: amount of use; FMA: Fugl-Meyer Assessment; MAL: Motor Activity Log; PNS: peripheral nerve stimulation; QOM: quality of movement; U/E: upper extremity; WMFT: Wolf Motor Function Test.
The numbers in pre- and post-intervention for upper limb function are the median (interquartile range).